Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India (Q35062842)

6 August 2017

title

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India (English)

1 reference

6 August 2017

1 reference

Pauline Joseph

1

1 reference

6 August 2017

Vijaya Bhaskara Rao Desai

2

1 reference

6 August 2017

Nalini Sunder Mohan

3

1 reference

6 August 2017

Jemima Sheila Fredrick

4

1 reference

6 August 2017

Rajeswari Ramachandran

5

1 reference

6 August 2017

Balambal Raman

6

1 reference

6 August 2017

Fraser Wares

7

1 reference

6 August 2017

Ranjani Ramachandran

8

1 reference

6 August 2017

Aleyamma Thomas

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Indian Journal of Medical Research

6 August 2017

published in

1 reference

6 August 2017

volume

133

1 reference

6 August 2017

page(s)

529-534

1 reference

Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Seven-year DOTS-Plus pilot experience in India: results, constraints and issues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121285

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21623039

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21623039

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

3121285

1 reference

6 August 2017

1 reference